Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |